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Abstract 
The research paper uncovers the socioeconomic factors which are associated with the recovery of 
coronavirus in Pakistan. Using a self-designed questionnaire, we collected the data from 170 
corona recovered patients and applied Multiple linear regression to predict the effect of 
socioeconomic factors. The paper finds that patients aged between 36 and 46 years take around 3 
more days to recover, whereas, patients aged above than 46 years take around 7 more days to 
recover in comparison to the young adults (17-25 years). In addition, patients who live in urban 
areas recover almost 1.5 days earlier than those who live in rural areas. Patients who have other 
serious diseases take almost 1.7 more days to recover in comparison to those who do not have any 
disease. Patients who smoke take 2 more days to recover in comparison to those who do not smoke. 
Moreover, obese people take almost 2.6 more days to recover in comparison to those who have a 
normal body mass index. Surprisingly, income, gender, and education remain insignificant in 
relation to the recovery days. We suggest, people above 46 should be given extra care, policies 
regarding smoking cessation, and lowering obesity should be implemented to combat coronavirus.    
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1. Introduction 
In December 2019, in Wuhan City, Hubei province China a total of 41 cases of pneumonia of 
unknown etiology were confirmed. Later on, a scientific team of the Chinese Academy of 
Engineering announced that the unknown virus was a new type of coronavirus and World Health 
Organization (WHO) tentatively named the virus as a 2019-new/novel coronavirus (2019-nCoV) 
(Lu et al., 2020). On 11th February 2020 WHO announced the official name of the virus as “Corona 
Virus Disease 2019” (COVID-19). The virus spreads through discharge from the nose, droplets of 
saliva when an infected person sneezes or coughs. The patients may have upper and lower 
respiratory tract, respiratory stress syndrome, hypoxemia, acute kidney injury, arrhythmia, and 
acute cardiac injury which may lead to multiple organ failure and finally cause death (Harapan et 
al., 2020). By examining at the spread and severity of the virus on 30th January 2020 as per the 
International Health Regulations WHO declared the COVID-19  as a Public Health Emergency of 
International Concern (Cascella et al., 2020) .  
Almost every country has been affected by COVID-19. As of 4th September 2020, the total 
world-wide cases of COVID-19 were 26.50 million, out of which 18.69 million people have been 
recovered and 873,822 117 died1. Every country has a different infection, recovery, and fatality 
rates caused by COVID-19. For instance, San Marino has the highest deaths per million (1,237) 
followed by Belgium, Peru, Andorra, Spain, United Kingdom, Italy, Sweden, Chile, and the USA. 
Conversely, Qatar has the highest per million recoveries (4,142), followed by French Guiana, 
Bahrain, San Marino, Chile, Kuwait, Oman, Vatican City, Panama, and Brazil2. Every country has 
adopted diverse health policies to combat the ill impacts of COVID-19. As of 4th September 2020, 
                                                          
1 https://www.worldometers.info/coronavirus/ 
2 Authors’ calculations using data from https://www.worldometers.info/coronavirus/ 
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no vaccine is available to prevent the COVID-19, however, antiviral drugs mixed with antibiotic 
treatment have also been used to treat COVID-19 patients (Huang et al., 2020). In addition, some 
socioeconomic factors, genetics, diseases history, level of immunity, and habits can affect the 
recovery of the COVID-19 patients. 
The rationale for using Pakistan as a case study (because of the better and easy data collection) 
was to explore the factors which were associated with the expedited recovery from the COVID-
19. Secondly, the impact of COVID-19 can vary among countries because of their heterogeneous 
characteristics such as government strategies, health facilities, epidemiological, clinical, and 
socioeconomic factors (Stojkoski et al., 2020).  As of 4th September 2020, Pakistan3 has 8,909 total 
active cases of COVID-19, total recoveries 282,268, and deaths 6,335. According to the total 
recoveries, Pakistan ranks 12th country of the world. The government has taken various steps to 
control the spread of the COVID-19 such as shutting down and limiting the flight operations (Abid 
et al., 2020), complete lockdown, regional lockdown (smart lockdown), compulsory wearing 
masks, social distancing, and increasing the awareness among people about the virus. Moreover, 
almost free medical treatment has been given to the patients, new field hospitals were built, tests 
for the COVID-19 have been subsidized in public hospitals. The government’s actions led to a 
positive impact on the recovery rate and the smart lockdown has reduced the spread of the COVID-
19 in Pakistan.  
Besides the government’s efforts, socio-economic factors of patients such as the area of living, 
race, obesity, gender, age, habits (exercising and smoking), marital status, the educational and 
economic background can also play a vital role in recovering from the COVID-19. Therefore, it is 
                                                          
3 http://covid.gov.pk/stats/pakistan 
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immensely important for policymakers to understand the impact of these factors so that appropriate 
measures can be taken to increase the recovery rate or to reduce the fatality rate of COVID-19.  A 
few studies such as N. Chen et al., (2020), T. Chen et al., (2020), and Huang et al., (2020) have 
found clinical and epidemiological features of the deceased and recovered COVID-19 patients in 
China. However, socioeconomic and habitual factors associated with the recovery are unexplored 
in Pakistan. To our knowledge, this is the first study focusing on Pakistan and exploring the 
relationship between corona recovery and socio-economic and habitual factors. We collected the 
data from 170 corona recovered patients through social media during the time of lockdown and 
applied multiple linear regression for the statistical analysis. The paper is organized as follows, 
section 2 reviews the earlier studies, section 3 discusses data and variables, section 4 explains the 
methods used for the analysis, section 5 discusses the results and section 6 concludes the paper. 
2. Literature Review 
Literature regarding the determinants of COVID-19 is scarce mainly because of the emerging 
situation of the novel virus. However, few studies have attempted to explore the relationship 
between socioeconomic determinants and COVID-19. For instance, in China, Jin et al., (2020) 
using a publicly available data set of COVID 19 found that deceased patients were significantly 
older (65 years and above) than survivors (35-57 years). In addition, they found that almost 65% 
of deceased patients had one of the serious illnesses such as chronic obstructive pulmonary disease 
(COPD), diabetes, cardiovascular disease, and hypertension. However, that study used the simple 
statistics (mean, median, and standard deviation) and did not established the significant association 
between the socio-economic/clinical factors and COVID-19 survivors, as we have done in our 
study. 
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In another study in China, T. Chen et al., (2020) found that clinical factors were mainly 
responsible for patients’ deaths due to COVID-19. However, they also explored the social factors 
which can affect the fatality rate, e.g male patients aged above than 60 were noted at higher risk 
of dying of COVID-19. The researchers used the data from 113 deceased patients and applied 
simple statistics such as mean, median, standard deviation, t, and χ2 tests to report the results. 
Similarly, N. Chen et al., (2020) in China stated the epidemiological and clinical characteristics of 
COVID-19 deceased patients. Using data from 99 deceased patients they found that co-infection, 
old age, hypertension, and smoking history were the serious risk factors. Regarding smoking as a 
risk factor, a few review articles such as Alqahtani et al., (2020); Farsalinos, Barbouni, and Niaura, 
(2020); and Farsalinos, et al., (2020) have summarized that there was a positive association 
between smoking and fatality rate, implying that people who smoke are at greater risk of dying of 
COVID-19. However, Berlin et al., (2020) placed emphasis on investigating the role of smoking 
in the COVID-19 pandemic. 
Likewise, Cai et al., (2020) in China explored the relationship between obesity and the severity 
of COVID-19 disease. They collected data from 383 patients of COVID-19 and applied 
multivariable logistic regression to examine the factors associated with the severity of COVID-19. 
The authors found that patients who were overweight had 1.84 times and those who were obese 
had 3.4 times more probability to develop severe COVID-19. Similarly, Stefan et al., (2020) found 
that older age (above 65), pre-existing diseases (cardiovascular disease, hypertension, diabetes, 
hypertension, and cancer), and obesity may be associated with the severity of the COVID-19. 
However, they used a small sample of 24 patients only and implemented simple statistics to explore 
the factors associated with the severity of the COVID-19 which may lead to weak estimates. 
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There are few studies which had been carried out at the national or at the macro level such as 
Stojkoski et al., (2020) and Coccia, (2020) which explored the factors that can affect the COVID-
19. However, we have only included the individual level studies because of their direct relevance 
to our study.  
To our knowledge, to date (4th September 2020) no study has found the socio-economic and 
habitual determinants of COVID-19 recovery in Pakistan. Most of the studies have been carried 
out in China where mostly epidemiological and clinical factors have been explored. As we have 
stated earlier, the factors which can affect the COVID-19 recovery or fatality rate may differ from 
country to country because of the heterogeneous environment. Therefore, we believe our study 
contributes to the existing literature significantly and provides in-depth insight for policymakers. 
The countries that match with Pakistan in terms of customs, environment, economic conditions, 
and other population characteristics such as India, Bangladesh, Nepal, Iran, and Afghanistan that 
may also get policy directions from our study.                 
3. Methods 
3.1 Data 
A short questionnaire was developed to collect the data. The generated link was sent to the 
COVID-19 recovered patients through different social media channels such as Email, WhatsApp, 
Facebook, and other communication sources. We asked 34 questions which could have taken 
around 7 minutes to answers. Only those patients were contacted who were willing to participate 
in the research study, they were further requested to provide consent to use their data for research 
purposes only. They also had options to exit the survey at any point as well as they had the option 
to hide their identities or personal data. In total, we collected data from 229 respondents, out of 
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which we dropped incomplete cases and were left with 170 observations. The respondents were 
mainly from big cities of Pakistan such as Karachi, Lahore, Faisalabad, and Peshawar. In total, we 
collected data from almost twenty cities of Pakistan. The questionnaire was also translated to the 
Pakistani national language (Urdu) so that the maximum patients could understand the questions. 
However, we have a highly educated cohort with the mean schooling years of 14. Secondly, our 
sample has the mean household expenditure (a proxy of income) equal to PKR 65,565 (USD 396 
(exchange rate 4th September 2020)), this is higher than the average national household 
expenditures PKR 41,545 (USD 251 (exchange rate 4th September 2020))4. Because the data were 
collected through the internet, only those patients were contacted who were able to operate and 
afford expensive gadgets. Therefore, our sample is also considered a resourceful sample and have 
less variation in education and income. There was thus a beneficial trade-off between bias and 
homogeneity of patients considered.  
3.2 Variables 
The dependent variable “Disease Days” was generated by subtracting the date of diagnosis from 
the date of recovery. Both dates were available as per the laboratory test results. The variable was 
a continuous variable with a minimum of 10 days and a maximum of 43 recovery days. The mean 
recovery days were 21 with a standard deviation of 5.6. All other variables are given in the table 
1 and 2 were considered as independent variables. Only schooling years and household 
expenditures were considered as continuous variables and the remaining variables were considered 
as categorical variables. The minimum age of the respondents was 17 and the maximum age was 
                                                          
4 https://www.ceicdata.com/en/pakistan/household-integrated-economic-survey-average-monthly-income-
household/average-monthly-income-household 
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77 years (meaning that patients can survive even in the age of 77). However, the virus can cause 
death to a patient of any age, race, gender, weight, education, and income group.   
We have taken two habitual variables such as currently smoking and exercising refer to table 
2 for details. Moreover, we have included other variables such as area, gender, marital status, 
admitted to the hospital, medicine taken, and any other pre-existing diseases. We calculated the 
body mass index (BMI) using the respondents’ weight and height and categorized them as follows, 
underweight means below 18.5 BMI, healthy or normal weight ranges 18.5 to 24.9 BMI, 
overweight ranges 25 to 29.9 BMI, and obese means 30 and above than 30 BMI, the number of 
respondents in each category can be seen in table 2.         
3.3 Statistical analysis 
For statistical analysis, we applied multiple linear regression to examine the association between 
COVID-19 recovery days and the independent variables. The regression predicts, how many days 
a patient would require to be COVID-19 negative. The linear regression is widely used in the 
literature and recently few studies such as Ayyoubzadeh et al., (2020), Kass et al., (2020), and 
Xiong et al., (2020) have used this method for predicting the impact of various factors upon 
COVID-19. Equation 1 represents the econometric expression:  𝑦𝑖 = 𝛽0 + 𝛽𝑖𝑥𝑖 + 𝜀   (1) 
 Where, 𝑦𝑖 = Disease days (the number of days a respondent was COVID-19 positive) 𝛽0 = Intercept terms / constant term 𝛽𝑖 = The coefficients of independent variables 
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𝑥𝑖 = All explanatory variables (Age, Gender, Education, living area, Marital status, log of income, 
any other disease, exercise, hospital admission, medicine taken, smoking, and BMI)  
The assumptions of linear regression [a) Linear in parameters b) zero mean of the residuals c) 
homoscedasticity d) no autocorrelation of residuals and e) independent variables and residuals 
were uncorrelated and f) multicollinearity] were fulfilled and can be seen in the appendix figure 
A1. The analysis was carried out using RStudio and mainly two packages, “dplyr” and “tidyverse”. 
4. Results and discussion 
Table 1 and 2 present a description of the variables. The tables are self-explanatory and show our 
respondents’ typology.  
Table 1. Description of the continuous variables 
Continuous Variables Observations Mean Std. Deviation Min Max 
Disease days (Dependent Variable) 170 21.42 5.656 10 43 
Schooling Years 170 14.95 2.07 8 20 
Monthly exp (PKR) 170 65,565 47,053 10,000 300,000 
Note: Authors’ calculations 
Table 2. Description of the categorical variables 
Factors Variables Frequencies Total 
Age Age 17-25 = 33 (19.4%) 
Age 26-35 = 81 (47.6%) 
Age 36-45 = 35 (20.6%) 
Age 46-above = 21 (12.4%) 
170 
Gender Male = 121 (71.2%) Female = 49 (28.8%) 170 
Area Urban = 128 (75.3%) Rural = 42 (24.7%) 170 
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Marital Status Single = 60 (35.3%) Married = 110 (64.7%) 170 
Any other disease Yes = 60 (35.3%) No = 110 (64.7%) 170 
Light exercise (walk) Yes = 65 (38.2%) No = 105 (61.8%) 170 
Admitted to the hospital Yes = 18 (10.6%) No =152 (89.4%) 170 
Medicine taken Yes = 153 (90.0%) No = 17 (10.0%) 170 
Smoking Yes = 38 (22.4%) No = 132 (77.6%) 170 
BMI-categories Normal BMI = 76 (44.7%) 
Obese = 34 (20.0%) 
Under BMI = 3 (1.8%) 
Over BMI = 57 (33.5%) 
170 
Note: Authors’ calculations 
Table 3 presents the main results of multiple linear regression, we assume that everyone 
recovers from COVID-19 because of our data limitation. We found patients aged 36 to 45 years 
old take 3 more days to recover (95% C.I = -0.33 - 6.05) as compared to the 17 to 25 aged patients. 
Likewise, patients aged 46 and above take 7 more days to recover (95% C.I = 3.62 – 10.93) from 
COVID-19 as compared to 17 to 25 years old. Perhaps due to the low immunity against the virus, 
the findings are similar to various studies such as Jin et al., (2020) and T. Chen et al., (2020). 
Interestingly, patients living in urban areas recover 1.5 days quicker (95% C.I = -3.34– 0.27) than 
those who live in rural areas. This may be because of the availability of better health facilities in 
urban areas. Similarly, the patients who had any pre-existing disease (e.g diabetes, cardiovascular 
disease, liver infection, and hypertension) take 1.7 more days to recover (95% C.I = -0.22 – 3.72) 
as compared to those who do not have any other pre-existing condition. The findings accord with 
the earlier studies (Jin et al., (2020) and T. Chen et al., (2020)) which have found that patients with 
pre-existing conditions were at more risk.    
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Interestingly, patients who currently smoke take 2 more days to recover (95% C.I = 0.03 – 
3.88) as compared to the non-smoker. Smoking is a major risk factor for lung diseases, bacterial, 
and viral infections (Berlin et al., 2020), and can cause severe damage to health. Finally, obese 
patients (having more than and equal to 30 BMI) take 2.6 more days to recover (95% C.I = 0.51– 
4.66) as compared to those patients who have normal weight (BMI 18.5 to 29.5). Obesity can be 
an increased risk of respiratory infections and may slow down the recovery process. Our findings 
are consistent with Cai et al., (2020) and Stefan et al., (2020).  
Surprisingly, income and education remain insignificant, implying that income and education 
do not expedite the recovery from the COVID-19 in Pakistan. Possibly, because of two main 
reasons i) most of the medicine and testing were subsidized by the government of Pakistan, hence, 
belonging to the lower or higher income groups may not affect the recovery process significantly. 
The second reason could be our data limitation, as stated earlier we had mostly higher income data 
and low variation in the data may not produce the significant results. Likewise, better education 
may save people from getting an infection because of better strategies, awareness, or following the 
guidelines. However, once educated people get infected they may have an equal chance of recovery 
to the less educated people.     
Table 3. Multiple linear regression results 
Variables estimate std. error t-statistic P-values 
95% C.I 
   Lower         Upper 
Age 26-35 0.443 1.225 0.362 0.718 -1.98 2.86 
Age 36-45 2.855* 1.616 1.766 0.079 -0.34 6.05 
Age 46-above 7.274*** 1.851 3.929 0.000 3.62 10.93 
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Age 17-25 (reference category) 
   
  
Gender Male -0.324 0.899 -0.36 0.72 -2.10 1.45 
Year of schooling -0.135 0.205 -0.657 0.512 -0.54 0.27 
Area Urban -1.537* 0.915 -1.68 0.095 -3.34 0.27 
Marital status Single 0.79 1.06 0.745 0.457 -1.30 2.88 
Log Income (proxy) 0.367 0.703 0.523 0.602 -1.02 1.76 
Any other disease Yes 1.750* 1.001 1.748 0.082 -0.23 3.73 
Exercise Yes -0.726 0.805 -0.903 0.368 -2.32 0.86 
Hospital admission Yes -0.163 1.375 -0.118 0.906 -2.88 2.55 
Medicine taken Yes -0.107 1.331 -0.081 0.936 -2.74 2.52 
Smoking Yes 1.957** 0.973 2.011 0.046 0.03 3.88 
Obese 2.585** 1.049 2.465 0.015 0.51 4.66 
Over weight 0.469 0.946 0.496 0.621 -1.40 2.34 
Under weight -1.636 3.102 -0.527 0.599 -7.76 4.49 
Normal Weight (reference category)  
   
  
(Intercept) 17.534** 7.689 2.28 0.024 2.34 32.73 
Observations 170   
R2 0.306   
Adjusted R2 0.234   
Residual Std. Error 4.953 (df = 153)         
F Statistic 4.221*** (df = 16; 153)   
Note: Authors’ calculation, C. I= Confidence intervals, P-value <0.005 ***, < 0.05 ** < 0.10 * 
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 The recovery or survival from the COVID-19 depends upon the severity of the disease as well. 
If the virus has infected the patient severely the recovery may take months or even lead to death. 
Our cohort mainly experienced fever and tiredness, followed by loss of taste and smell, body aches, 
headache, cough and sneezing, sore throat, diarrhea, difficulty in breathing, and chest pain. Figure 
1 shows the symptoms which patients had experienced during COVID-19. 
 
 
 
 
 
 
 
 
 
 
 
 
5. Conclusions 
COVID-19 has imposed substantial health and economic burdens on every country. As of 4th 
September 2020, no vaccination against COVID-19 is available on the market. However, around 
20 vaccines are under development currently (Evans, 2020) which could potentially be available 
soon. Therefore, extra care should be taken to lower the spread of the virus by following the 
guidelines introduced by the WHO and local governments. Currently, every country is trying to 
increase the recovery rate of coronavirus by adopting numerous health strategies such as test, track, 
and trace whilst maintaining stringent hygiene and social distancing. Researchers are still 
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Figure 1. Symptoms of COVID-19 patients in our cohort. 
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attempting to identify the factors which can reduce the adverse impact of COVID-19 upon the 
global community. A few studies have attempted to find the epidemiological and clinical features 
of deceased and survivors of COVID-19 patients. However, the association between the COVID-
19 and patients’ socioeconomic attributes are still unexplored, especially in Pakistan. It is 
immensely important for policymakers to understand the impact of the socioeconomic factors on 
COVID-19 so that appropriate measures can be adopted for current and future pandemic responses. 
We found that old age, having pre-existing diseases, smoking, and obesity slows down the 
recovery process from COVID-19 in Pakistan. We suggest that the government of Pakistan should 
provide extra care to older age patients and those who have pre-existing diseases especially 
diabetes, cardiovascular diseases, hypertension, and respiratory diseases. Moreover, the 
government should adopt the smoking cessation policies as well as encourage those policies which 
can lower the obesity in the country to enhance the recovery rate in Pakistan. Our results are likely 
to be applicable to policy setters in many other countries around the world. 
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Appendix 
Figure A1 shows the assumption of multiple linear regression holds.  
 
 
 
 
 
 
 
Figure A1. multiple linear regression assumptions 
